Literature DB >> 16679807

Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening.

J Carlos Pastor1, M Carmen Méndez, Miguel A de la Fuente, Rosa M Coco, José García-Arumí, Enrique Rodríguez de la Rúa, Nieves Fernández, M Antonia Saornil, Manuel J Gayoso.   

Abstract

UNLABELLED: To report the major intraretinal pathological changes in retinas with proliferative vitreoretinopathy (PVR) and retinal shortening, 13 human retinal samples from postoperative PVR after primary surgery for retinal detachment were immunostained for vimentin, glial fibrillary acidic protein (GFAP), cytokeratins, and CD68. One more sample was studied with electron microscopy. Retinal disorganization, neuronal loss, and gliosis were observed in 12 out of 13 samples, but all 13 were positive for GFAP. Muller cell processes showed different degrees of intermediate filament hyperplasia. CD68-positive cells were present in 11 of 13 retinal samples.
CONCLUSION: A gliotic response plays a major role in retinal shortening in PVR. In addition, the presence of macrophage-like cells in retinal tissues suggests a possible role of these cells in the pathogenesis of this variety of PVR. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679807     DOI: 10.1159/000093070

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  14 in total

1.  In vitro biomechanical modulation--retinal detachment in a box.

Authors:  Fredrik Ghosh; Karin Arnér; Linnéa Taylor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-12-12       Impact factor: 3.117

2.  Changes in the retinal inner limiting membrane associated with Valsalva retinopathy.

Authors:  S K Gibran; N Kenawy; D Wong; P Hiscott
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

Review 3.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

4.  High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up.

Authors:  Dirk Sandner; Erdmuth Herbrig; Katrin Engelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.535

5.  Müller and macrophage-like cell interactions in an organotypic culture of porcine neuroretina.

Authors:  Ivan Fernandez-Bueno; Jose Carlos Pastor; Manuel Jose Gayoso; Ignacio Alcalde; Maria Teresa Garcia
Journal:  Mol Vis       Date:  2008-11-28       Impact factor: 2.367

6.  Retinal shortening: Ultrasonic evaluation of proliferative vitreoretinopathy.

Authors:  Brijesh Takkar; Shreyas Temkar; Nripen Gaur; Pradeep Venkatesh; Rohan Chawla; Atul Kumar
Journal:  Indian J Ophthalmol       Date:  2017-11       Impact factor: 1.848

7.  Adalimumab (tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina.

Authors:  I Fernandez-Bueno; M T Garcia-Gutierrez; G K Srivastava; M J Gayoso; J M Gonzalo-Orden; J C Pastor
Journal:  Mol Vis       Date:  2013-04-17       Impact factor: 2.367

8.  The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.

Authors:  Salvador Pastor-Idoate; Irene Rodríguez-Hernández; Jimena Rojas; Itziar Fernández; María T García-Gutiérrez; José M Ruiz-Moreno; Amandio Rocha-Sousa; Yashin Ramkissoon; Steven Harsum; Robert E MacLaren; David Charteris; Jan C VanMeurs; Rogelio González-Sarmiento; José C Pastor
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

Review 9.  Classifications for Proliferative Vitreoretinopathy (PVR): An Analysis of Their Use in Publications over the Last 15 Years.

Authors:  Salvatore Di Lauro; Mustafa R Kadhim; David G Charteris; J Carlos Pastor
Journal:  J Ophthalmol       Date:  2016-06-27       Impact factor: 1.909

10.  Small Interfering RNA Targeted to ASPP2 Promotes Progression of Experimental Proliferative Vitreoretinopathy.

Authors:  Xiao-Li Chen; Yu-Jing Bai; Qin-Rui Hu; Shan-Shan Li; Lv-Zhen Huang; Xiao-Xin Li
Journal:  Mediators Inflamm       Date:  2016-06-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.